![Erik Strömqvist](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Erik Strömqvist
Direktor/Vorstandsmitglied bei
XVIVO PERFUSION AB
Vermögen: 48 391 $ am 31.07.2026
Profil
Currently, Erik Strömqvist is Chairman at MedTrace Pharma AS since 2024, Independent Director at Xvivo Perfusion AB since 2023, Director at Atley Solutions AB since 2021, and Chief Operating Officer at Swiss Nuclides AG.
Formerly, Mr. Strömqvist was Independent Director at Studsvik AB from 2021 to 2026, Director at Celcibus AB from 2020 to 2023, President at Swiss Nuclides Sweden AB, and General Manager-Cyclotrons & TRACERcenter at GE Healthcare AB from 2009 to 2020.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
XVIVO PERFUSION AB 0.01% | 31.12.2025 | 1’750 ( 0.01% ) | 48 391 $ | 31.07.2026 |
Aktive Positionen von Erik Strömqvist
| Unternehmen | Position | Beginn |
|---|---|---|
| XVIVO PERFUSION AB | Direktor/Vorstandsmitglied | 01.01.2023 |
Swiss Nuclides AG
 Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Geschäftsführer | - |
Atley Solutions AB
 Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Direktor/Vorstandsmitglied | 01.06.2021 |
MedTrace Pharma AS
 MedTrace Pharma AS Medical SpecialtiesHealth Technology Provides medical devices for hospital departments | Vorsitzender | 01.01.2024 |
Ehemalige bekannte Positionen von Erik Strömqvist
| Unternehmen | Position | Ende |
|---|---|---|
| STUDSVIK AB | Direktor/Vorstandsmitglied | 21.01.2026 |
Celcibus AB
 Celcibus AB Electronic Equipment/InstrumentsElectronic Technology Manufactures hydrogen fuel cells | Direktor/Vorstandsmitglied | 01.06.2023 |
GE Healthcare AB
 GE Healthcare AB Pharmaceuticals: MajorHealth Technology Wholesales and distributes pharmaceutical products | Corporate Officer/Principal | 01.06.2020 |
Swiss Nuclides Sweden AB | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
56
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Studsvik AB
 Studsvik AB Miscellaneous Commercial ServicesCommercial Services Provides decommissioning and radiation protection services | Commercial Services |
GE Healthcare AB
GE Healthcare AB Pharmaceuticals: MajorHealth Technology Wholesales and distributes pharmaceutical products | Health Technology |
Xvivo Perfusion AB
 Xvivo Perfusion AB Medical SpecialtiesHealth Technology Operates as a medical technology company which develops solutions for organ, tissue, and cell preservation | Health Technology |
MedTrace Pharma AS
MedTrace Pharma AS Medical SpecialtiesHealth Technology Provides medical devices for hospital departments | Health Technology |
Atley Solutions AB
Atley Solutions AB Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company | Commercial Services |
Celcibus AB
Celcibus AB Electronic Equipment/InstrumentsElectronic Technology Manufactures hydrogen fuel cells | Electronic Technology |
Swiss Nuclides AG
Swiss Nuclides AG Hospital/Nursing ManagementHealth Services Provides cancer patients diagnostics and radiopharmaceutical therapy treatment services | Health Services |
Swiss Nuclides Sweden AB |
